Skip to main content
. 2017 Jun 27;14(2):1846–1852. doi: 10.3892/etm.2017.4682

Figure 4.

Figure 4.

Activation of CD27+IgM+B cell subsets in patients with CHC. (A) Gating strategy to detect IgM+B cell subsets and activation markers. (B) Frequencies of CD21-B cells in IgM+B subsets. (C) Expression of CD86 in CD27+IgM+B cells. (D) Expression of CD95 in CD27+IgM+B subsets. *P<0.05. CHC, chronic hepatitis C; HC, healthy control; NS, no significant difference; PE, phycoerythrin; APC, allophycocyanin; FITC, fluorescein isothiocyanate; MFI, mean fluorescence intensity; Ig, immunoglobulin; CD, cluster of differentiation.